SMMT Competitors & Alternatives
Compare Summit Therapeutics PLC with similar stocks in the same industry
Biotechnology
SMMT
Main Stock$15.55
Tradestie Score
50
Market Cap
$15.22B
Revenue Growth
-1.0%
Analyst Upside
+94.7%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.75
|
$15.70B | 33.1 | 44 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$242.99
|
$12.36B | 18.3 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$65.31
|
$11.09B | 20.4 | 38 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$37.45
|
$10.76B | - | 54 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$202.63
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.63
|
$10.53B | 149.2 | 67 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$43.91
|
$10.49B | - | 58 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$68.12
|
$10.22B | - | 58 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$453.34
|
$10.01B | - | 62 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.62
|
$9.33B | 62.6 | 61 | Compare |
More SMMT Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry